Galsulfase comment watch save

  • TRADE NAME: Naglazyme (BioMarin)
  • INDICATIONS: Mucopolysaccharidosis
  • CLASS: Enzyme
  • HALF-LIFE: 9–26 minutes
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    None known

Please login to view the rest of this drug profile.

Page last updated 07/31/2023

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric

Back to top